Semaglutide: Nonarteritic Anterior Ischemic Optic Neuropathy in the FDA adverse event reporting system – A disproportionality analysis
Marina Azab, Luca Pasina
Topics & Concepts
MedicineAnterior ischemic optic neuropathySemaglutideOptic neuropathyAdverse effectOphthalmologyInternal medicineOptic nerveDiabetes mellitusType 2 diabetesEndocrinologyLiraglutideCerebrovascular and Carotid Artery DiseasesAntiplatelet Therapy and Cardiovascular DiseasesPeripheral Artery Disease Management